DIABETIC PTS RECIPIENTS OF RENAL ALLOGRAFTS USING THE EDMONTON PROTOCOL IMMUNO

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。列出的机构是 中心，不一定是研究者的机构。 本研究的目的是确定埃德蒙顿胰岛移植方案（他克莫司，西罗莫司和少量或无泼尼松）是否会改善既往肾移植的1型糖尿病患者的胰岛细胞移植。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to determine if the Edmonton islet transplant protocol (tacrolimus, sirolimus and little or no prednisone) will improve islet cell transplantation in Type 1 diabetic patients with a previous kidney transplant.